IDBiologics, Inc. — Form D
IDBiologics, Inc. of NASHVILLE, TN, a company, filed a Form D exempt-offering notice with the SEC on 2020-05-20. The offering totals $3.5M, of which $3.1M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2020-05-20
- Form: D
- Accession: 0001812623-20-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $3.5M
- Amount sold: $3.1M
- Remaining: $400K
- Minimum investment: $1
- Investors: 13
- Date of first sale: 2020-05-05
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-367393
Issuer
- Name: IDBiologics, Inc.
- CIK: 0001812623
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2017
- Address: 2101 20TH AVE SOUTH, NASHVILLE, TN, 37212
- Phone: (408) 899-9356
Officers, directors & promoters (5)
| Name | Role | Location |
|---|
| Charles F Haines | Director | Nashville, TN |
| Charles F Haines | Executive Officer | Nashville, TN |
| Kenneth J Kelley | Director | Nashville, TN |
| James E Crowe, Jr. | Director | Nashville, TN |
| Mike E LaBarre | Director | Nashville, TN |
Other filings by this issuer (1)
More